MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹29 Cr | ₹42 Cr | ₹41 Cr | ₹19 Cr | ₹19 Cr |
What is the latest Total Debt ratio of MARKSANS PHARMA ?
Year | Total Debt |
---|---|
Mar2024 | ₹29 Cr |
Mar2023 | ₹42 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹19 Cr |
How is Total Debt of MARKSANS PHARMA Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹29 Cr | -30.05 | |
Mar2023 | ₹42 Cr | 0.72 | |
Mar2022 | ₹41 Cr | 120.34 | |
Mar2021 | ₹19 Cr | -0.78 | |
Mar2020 | ₹19 Cr | - |
Compare Total Debt of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,438.8 Cr | -4.7% | -14% | 64.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,400.0 Cr | 2% | -0.9% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,622.0 Cr | -1.6% | -0.4% | 57.3% | Stock Analytics | |
CIPLA | ₹116,240.0 Cr | -0.3% | -2.5% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,166.0 Cr | -0.5% | -3.3% | 14% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,495.2 Cr | -1% | 0.6% | 39.1% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -4.7% |
-14% |
64.1% |
SENSEX | -0.4% |
-2.1% |
6.9% |
You may also like the below Video Courses